Did you know that the top question cat owners asked Google in 2024 was "Why is my cat peeing everywhere?" On #InternationalCatDay, we dive deeper into this issue. Learn more about possible causes and what you can do 👇 #LifeForward
Boehringer Ingelheim
Arzneimittelherstellung
Ingelheim am Rhein, Rhineland-Palatinate 1.823.105 Follower:innen
Info
Unsere Mitarbeitenden sind unsere Stärke. Gemeinsam mit über 53.000 Kolleg*innen schaffen wir den nächsten Durchbruch: neue Innovationen für die Gesundheit von Menschen und Tieren.
- Website
-
http://www.boehringer-ingelheim.com
Externer Link zu Boehringer Ingelheim
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Ingelheim am Rhein, Rhineland-Palatinate
- Art
- Privatunternehmen
- Spezialgebiete
- Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals und Contract Manufacturing
Orte
Beschäftigte von Boehringer Ingelheim
-
Gwen Whitfield Foster
-
Thomas Macauley
Research Data Management - Lab Services Engineer at Boehringer-Ingelheim
-
Mitchell Taub
Highly Distinguished Research Fellow
-
Ralf Schundelmeier
Product Leader (ex Salesforce) - Building Platforms for Applications, GenAI / Machine Learning & Data
Updates
-
We've discovered a promising new approach to target KRAS-driven cancers. 1 in 7 cancer patients have a mutation in the #KRAS gene, which plays a crucial role in regulating cell division in our bodies. When there is a mutation, cells keep dividing and growing uncontrollably, which can lead to the formation of a tumor. We’ve discovered a way to potentially treat KRAS-driven cancer and delay the onset of drug resistance using a novel drug combination. Our groundbreaking research was published in Nature Cancer and was possible through our collaboration with the MD Anderson Cancer Center. Learn more: https://lnkd.in/ec3sqf35 #Cancer #ResearchAndDevelopment
-
We believe in the power of diverse perspectives and support our employees to go where their talents can make the biggest impact. Their growth is our growth. Meet Pia Schall. She develops her own career path with us. Until today, it took her from Germany to South Korea, and now France. Curious about how Pia's career became borderless? Find out how our International Mobility team played a part: https://lnkd.in/e3GX3ztn
-
Wondering what we have in common with dinosaurs? While those huge animals succumbed to drastic environmental conditions, some microscopic creatures that lived with them showed resilience to survive until today: parasites! ➡️ https://lnkd.in/eeEDibE7
-
In 2020, 75% of trial participants for approved molecular entities and therapeutic biologics in the USA were White. In our new episode of ‘Journeys Through Pulmonary Fibrosis’, our guests discuss how there should be more encouragement towards people from all backgrounds to learn more about the outcomes of trials, aiming to improve the future care pathway of people living with PF. Watch the full episode now: https://bit.ly/4c6UDqL
-
Shockingly, people with schizophrenia or other serious mental illnesses die 10 to 20 years earlier than the general population. Nedim Pipic, MD, MSc, touched on this heartbreaking truth as he explored significant gaps in mental health care for Devex. By addressing stigma and changing mindsets, he explains, we can unlock greater outcomes for everyone with a mental health condition. #LifeForward #MentalHealth
Supporting better #mentalhealth is central to achieving many of the United Nations 2030 Sustainable Development Goals. So, how can policymakers take action and start delivering on their commitments? https://bit.ly/3Lzfpo3 #Sponsored by Boehringer Ingelheim #healthpolicy #SDGs
-
Boehringer Ingelheim hat dies direkt geteilt
Did you know that, in the EU, lung cancer accounts for about 20% of all deaths due to cancer? LuCE and its members are calling for increased access to early and accurate diagnosis of lung cancer in Europe. Let's act now. World Lung Cancer Day, August 1st, 2024. #ActNow #ActionNow #WorldLungCancerDay #WorldLungCancerDay24 #WorldLungCancerDay2024 #WLCD #WLCD24 #WLCD2024 #LungCancerDay #LungCancerPatients #patientsright #patientsvoice #LuCE #LungCancerEurope
-
#NEWS: We have acquired Nerio Therapeutics. Why? Their knowledge will help us to fight cancer by activating our own immune system. Learn more on why we have added their small molecule checkpoint inhibitor to our oncology pipeline: https://lnkd.in/e9i3SdqY #Cancer #ImmunoOncology #ResearchAndDevelopment
-
#NEWS: The European Committee for Medicinal Products for Human Use (CHMP) recommends approval of new and expanded indications for our generalized pustular psoriasis (#GPP) treatment option. Learn more here: https://lnkd.in/eCXSSm_E #Dermatology
-
Early and confident detection of disease progression is crucial for people living with fibrosing lung disease. Through our partnership with Brainomix, we want to help revolutionize the diagnostic landscape and thereby enable earlier treatment decisions. Learn more about the partnership below.
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease The project will evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US. Michalis Papadakis: "There is an urgent need to improve the identification of people with fibrosing lung disease. This will enable earlier access to specialist care and the opportunity for faster initiation of treatment, which can slow the worsening of the disease. The patient pathway for people with fibrosing lung disease is currently fragmented and it can take many years for a patient to be diagnosed. "This partnership enables us to leverage our established experience and expertise connecting stroke networks to develop a similar network model of care for patients with fibrosing lung disease, generating real-world evidence that will drive the opportunities we have with e-Lung to help improve outcomes for patients and their families." Read more about this partnership: ⬇ https://lnkd.in/eFhtvQhE Boehringer Ingelheim #eLung #ai #fibrosinglungdisease #BI #partnership #USA #lung #Brainomix360
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease
prnewswire.com